A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the hip

Journal of Rheumatology

Volumn 24, Issue 2, 1997, Pages 349-357

  Towheed, Tanveer E ^a,b   Hochberg, Marc C ^a,c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c Dept Med Epidemiol Prev Med ^*

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

hip; osteoarthritis; randomized controlled trials; therapy

Indexed keywords

CARPROFEN; CODEINE; DEXTROPROPOXYPHENE; DIACETYLRHEIN; DICLOFENAC; DIHYDROCODEINE; FENBUFEN; FEPRAZONE; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; INDOPROFEN; ISOXICAM; KETOPROFEN; NAPROXEN; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYLBUTAZONE; PIROXICAM; PROQUAZONE; SULINDAC; TENOXICAM; TOLMETIN; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG EVALUATION; HIP; HIP JOINT; HUMANS; MEDLINE; OSTEOARTHRITIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS;

EID: 0031042019     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Scott JC, Hochberg MC: Arthritic and other musculoskeletal diseases. In: Brownson RC, Remington PL, Davis JR, eds. Chronic Disease Epidemiology and Control. Washington: American Public Health Association, 1993.
2. Arthritis prevalence and activity limitations - United States, 1990. MMWR 1994;43:433-8.
3. Morales-Torres J, Reginster JV, Hochberg MC: Rheumatic and musculoskeletal diseases and impaired quality of life - a challenge for rheumatologists. J Rheumatol 1996;23:1-3.
4. National Institutes of Health: Total hip replacement. NIH Consens Statement 1994;12:1-31.
5. Hochberg MC, Perlmutter DL, Hudson JI, Altman RD: Preferences in the management of osteoarthritis of the hip and knee: Results of a survey of community-based rheumatologists in the United States. Arthritis Care Res 1996;(in press).
6. Towheed TE, Hochberg MC: Health-related quality of life following total hip replacement. Semin Arthritis Rheum 1996;26:483-91.
7. Hochberg MC, Altman RD, Brandt KD, et al: Guidelines for the medical management of osteoarthritis. I. Osteoarthritis of the hip. Arthritis Rheum 1995;38:1535-40.
8. Griffin MR: Practical management of osteoarthritis: Integration of pharmacologic and nonpharmacologic measures. Arch Fam Med 1995;4:1049-55.
9. Batchelor EE, Paulus HE: Principles of drug therapy. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, eds. Osteoarthritis: Diagnosis and Medical/Surgical Management. Philadelphia: WB Saunders, 1995:465-87.
10. Gabriel SE, Jaakkimainen L, Bombardier C: Risk factors for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
11. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA: Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
12. Herman J, Appel AM, Khosla RC, Hess EV: The in vitro effect of select classes of nonsteroidal antiinflammatory drugs on normal cartilage metabolism. J Rheumatol 1986;13:1014-8.
13. Brandt KD: Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis? Rheum Dis Clin North Am 1993;19:29-44.
14. Brooks PM, Day RO: Nonsteroidal antiinflammatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
15. Gotzsche P: Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989;10:31-56.
16. Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. San Diego, CA: Academic Press, 1985.
17. Petitti DB: Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. New York: Oxford University Press, 1994.
18. Heller CA, Ingelfinger JA, Goldman P: Nonsteroidal antiinflammatory drugs and aspirin - analyzing the scores. Pharmacotherapy 1985;5:30-8.
19. Brocks BE: A comparison of flufenamic acid and phenylbutazone in osteoarthritis of the hip. Ann Physical Med 1966;(suppl)114-8.
20. Molony J, Quill J, Pigott PV: A double-blind trial of a new anti-inflammatory drug in the management of osteoarthritis of the hip joint. J Irish Med Assoc 1971;424:605-10.
21. Desproges-Gotteron R, Leroy V, Comte B: A double-blind comparison of alclofenac and indomethacin in osteoarthritis of the hip. Curr Ther Res 1971;13:393-7.
22. Owen-Smith BD, Burry HC: Ibuprofen in the management of osteoarthrosis of the hip. Rheum Phys Med 1972;11:281-6.
23. Hodgkinson R, Woolf D: A five-year clinical trial of indomethacin in osteoarthrosis of the hip. Practitioner 1973;210:392-6.
24. Bresnihan FP, Grahame R, Burry HC: Ketoprofen in the management of osteoarthrosis of the hip: Comparison with phenylbutazone. Rheumatol Rehab 1974;13:125-31.
25. Famaey JP, Colinet E: A double-blind trial of ketoprofen in the treatment of osteoarthritis of the hip. Rheumatol Rehab 1976;45-9.
26. Dieppe PA, Burry HC, Grahame R, Perera T: Sulindac in osteoarthrosis of the hip. Rheumatol Rehab 1976;15:112-5.
27. Caroit M, Forette B, Hubault A, Pasquier P: Double-blind study of ketoprofen against a placebo in osteoarthritis of the hip. Scand J Rheumatol 1976;14:123-7.
28. Cardoe N: Double-blind cross-over study of ketoprofen and phenylbutazone in patients with chronic osteoarthrosis of the hip. Rheumatol Rehab 1976;27-33.
29. Grahame R, Burry RC: Ketoprofen - a new anti-rheumatic agent. Scand J Rheumatol 1976;14:133-6.
30. Calabro J, Andelman S, Caldwell J, et al: A multicenter trial of sulindac in osteoarthritis of the hip. Clin Pharmacol Ther 1977;22:358-63.
31. Bain LS, Lynch MP, Bruce GM: A double-blind trial of feprazone in osteoarthritis of the hip. Curr Med Res Opin 1977;4:665-9.
32. Frank O: A double-blind comparative study of 150 mg flurbiprofen daily and 75 mg indomethacin daily in the treatment of osteoarthrosis of the hip joint. Curr Med Res Opin 1977;5:91-8.
33. Vainio JT, Lepisto PV: A long-term comparison of proquazone and naproxen in the treatment of osteoarthritis of the hip. Scand J Rheumatol 1978;21:25-7.
34. Car A, Jajic I, Krampac I, Vitaus M, Zenic N, Zivkovic M: A double-blind multicentre comparison of diclofenac sodium and naproxen in osteoarthrosis of the hip. Scand J Rheumatol 1978;22:63-8.
35. Davies J, Dixon AS, Steele CE: Tolmetin sodium and indomethacin in the treatment of osteoarthrosis of the hip: A double-blind crossover study. Curr Med Res Opin 1980;7:115-20.
36. Debelle M, Carlon J, Van der Mijnsbrugge J: Indoprofen. Short-term double-blind cross-over study in patients with osteoarthritis of the hip. Europ J Rheum Inflam 1981;103-6.
37. Knusel O: Double-blind comparative clinical trial of carprofen versus diclofenac-Na in patients with coxarthrosis. Europ J Rheum Inflam 1982;536-42.
38. Crook PR, Fowler PD, Hothersall TE, Chiswell RJ: A study of the efficacy and tolerability of diclofenac and ibuprofen in osteoarthritis of the hip. Br J Clin Pract 1982;309-12.
39. Young IH, Currie WJC: Osmosin in general practice: Preliminary report of a double-blind study in the treatment of osteoarthritis. Curr Med Res Opin 1983;8:99-108.
40. Alho A, Jaer O, Slungaard U, Holme I: Piroxicam and naproxen in patients with osteoarthritis of the hip waiting for total hip replacement. Clin Rheumatol 1988;7:208-13.
41. Kjaersgaard-Andersen P, Nafei A, Skov O, et al: Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomized double-blind, multi-centre study. Pain 1990;43:309-18.
42. Ersmark H, Tjornstrand B, Gudmundsson G, et al: Piroxicam and indomethacin suppositories for painful coxarthrosis. Clin Rheumatol 1992;11:37-40.
43. Quiding H, Grimstad J, Rusten K, Stubhaug A, Bremnes J, Breivik H: Ibuprofen plus codeine, ibuprofen, and placebo in a single and multidose cross-over comparison for coxarthrosis pain. Pain 1992;50:303-7.
44. Lloyd RS, Costello F, Eves MJ, James IG, Miller AJ: The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992;13:37-48.
45. Seideman P, Samuelson P, Neander G: Naproxen and paracetamol compared with naproxen only in coxarthrosis. Acta Orthop Scand 1993;64:285-88.
46. Nguyen M, Dougados M, Berdah L, Amor B: Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994;37:529-36.
47. Cochrane G: A double-blind comparison of naproxen with indomethacin. Scand J Rheumatol 1973;2:89-93.
48. Wojtulewski JA, Hart FD, Huskisson EC: Fenoprofen in treatment of osteoarthritis of hip and knee. BMJ 1974;2:475-6.
49. Blechman W, Willkens R, Boncaldo GL, Hoffmeister RT, Lockie LM, Multz C: Naproxen in osteoarthritis. Ann Rheum Dis 1978;13:80-4.
50. Valtonen EJ: Clinical comparison of fenbufen and aspirin in osteoarthritis. Scand J Rheumatol 1979;1-7.
51. Shephard NW, Steele CE: Comparison of tolmetin sodium with indomethacin in osteoarthritis. Clin Trials 1981;225:1696-7.
52. Levenstein JH: Isoxicam and indomethacin in acute osteoarthritis. S Afr Med J 1985;67:676-9.
53. Brown BL, Johnson JH, Hearron MS: Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis. Am J Med 1986;80:112-7.
54. Muller-Fassbender H: Double-blind clinical trial of s-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. Am J Med 1987;83:81-3.
55. Vetter G: Double-blind comparative clinical trial with s-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med 1987;83:78-80.
56. Amor B, Benarrosh C: A method for comparing analgesics: Glafenine and paracetamol multicenter cross-over approach. Clin Rheumatol 1958;7:492-7.
57. Williams PI, Hosie J, Scott DL: Etodolac therapy for osteoarthritis: A double-blind placebo-controlled trial. Curr Med Res Opin 1989;11:463-70.
58. Van Cauwenberge H, Ruhwiedel M, Albert A, Franchimont P: Comparative study of tilidine-naloxone and pentazocine in knee and hip osteoarthritis. Int J Clin Pharmacol Res 1992;22:1-9.
59. Doherty M: The efficacy of arthrotec in the treatment of osteoarthritis. Scand J Rheumatol 1992;96:15-21.
60. Barnes C, Goodman H, Eade A, et al: A double-blind comparison of naproxen with indomethacin in osteoarthrosis. J Clin Pharmacol 1975;15:347-54.
61. Germain BF, Dillard C, Levi L, et al: A placebo-controlled study of diclofenac sodium for the treatment of osteoarthritis of the hip and knee. Curr Ther Res 1985;37:259-68.
62. Altman R, Alarcon G, Appelrouth D, et al: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
63. Bellamy N, Buchanan WW, Goldsmith H, Campbell J, Stitt LW: Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
64. Lequesne M: Indices of severity and disease activity for osteoarthritis. Semin Arthritis Rheum 1991;20:48-54.
65. Meenan RF, German PM, Mason JH: Measuring health in arthritis: The Arthritis Impact Measurement Scale. Arthritis Rheum 1980;23:146-52.
66. Fries JF, Spitz P, Young DY: The dimensions of health outcomes: The health assessment questionnaire disability and pain scales. J Rheumatol 1982;9:789-93.
67. Todd PA, Clissold SP: Naproxen: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs 1990;40:91-137.
68. Day RO, Graham GG, Williams KM, Brooks PM: Variability in response to NSAIDs. Fact or fiction? Drugs 1988;36:643-51.
69. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S: Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62-73.
70. Sangha O, Liang MH: Assessment outcomes of clinical drug trials in osteoarthritis. Curr Opin Rheumatol 1995;7:352-5.
71. Dougados M: Clinical assessment of osteoarthritis in clinical trials. Curr Opin Rheumatol 1995;7:87-91.
72. Rosenbloom D, Brooks P, Bellamy N, Buchanan W: Clinical Trials in the Rheumatic Diseases. New York: Praeger, 1985:1-69.
73. Bellamy N, Carette S, Ford PM, et al: Osteoarthritis antirheumatic drug trials. 1. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol 1992;19:436-43.
74. Hedges L: Estimation of effect size from a series of independent experiments. Psychol Bull 1982;92:470-99.
75. Follmann D, Elliot P, Suh I, Cutler J: Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-73.
76. Gottlieb NL: The art and science of nonsteroidal anti-inflammatory drug selection. Semin Arthritis Rheum 1985;15:1-3.
77. Furst DE: Are there differences among nonsteroidal antiinflammatory drugs? Arthritis Rheum 1995;37:1-9.
78. Greene JM, Winickoff RN: Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. Arch Intern Med 1995;152:1995-2002.
79. Huskisson EC, Woolf DL, Balme HW, Scott J, Franklyn S: Four new anti-inflammatory drugs: Responses and variations. BMJ 1976;1:1048-9.
80. Gall EP, Caperton EM, McComb JE, et al: Clinical comparison of ibuprofen, fenoprofen, calcium, naproxen and tolmetin sodium in rheumatoid arthritis. J Rheumatol 1982;9:402-7.
81. Scott DL, Roden S, Marshall T, Kendall MJ: Variations in response to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol 1982;14:691-4.
82. Bradley JD, Brandt KD, Katz BP, Kalasinki LA, Ryan SL: Comparison of an inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
83. Lequesne M, Brandt K, Bellamy N, et al: Guidelines for testing slow acting drugs. J Rheumatol 1994;21:65-73.
84. Dougados M, De Vogeler JP, Annefeld M, et al: Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 1996;55:552-7.
85. Altman RD, Brandt KD, Hochberg MC, Moskowitz RW: Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 1996;(in press).